Sales Training 2021

Dr Wang Tianhua obtained his PhD at Penn Center for Molecular Discovery, University of Pennsylvania (UPenn) in 2011 under the supervision of Prof Scott Diamond with a research focus on developing therapeutics for blocking SARS, Ebola virus infection.

He then worked in Analytics group at Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research Singapore (A*STAR). Over the 5 years at BTI, he served as the Co-PI and lead PI of two research grants (GlycoSing and HighGlycoArt) in establishing High throughput glyco-analytics platform based on Liquid Chromatography Mass Spectrometry (LCMS) for protein therapeutics development.

Dr Wang Joined Shimadzu Asia Pacific as a product specialist in 2017. He is taking care of the life science related products and applications in the South East Asia and South Asia region.